About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Effectiveness of MyNutriKidney® | Clinical Trials | Clareo Health

Not Yet RecruitingNA

Clinical Effectiveness of MyNutriKidney®

Clinical Effectiveness of MyNutriKidney® for Dietary Self-management in Chronic Kidney Disease Patients: Protocol for a Pragmatic Randomized Controlled Trial

NCT06956872•Universiti Putra Malaysia

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Chronic Kidney Disease Stage 3Chronic Kidney DiseaseChronic Kidney Disease Stage 5+1 more

Interventions

Counseling

Renal Diet App

+1 more

Locations

1

Malaysia

Locations (1)

Sultan Idris Shah Hospital, Serdang

Kajang, Selangor, Malaysia

Key Dates

Start Date

July 1, 2025

Primary Completion Date

February 1, 2027

Completion Date

February 1, 2027

Last Updated

May 4, 2025

Related Studies

A Natural History Study of Metabolic Sizing in Health and Disease

NCT05398783

Metabolic DisordersCancer+3 more

Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome

NCT07547098

Cardiovascular Diseases (CVD)Chronic Kidney Disease+2 more

RECRUITINGPhase 3

A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria

NCT05196035

Chronic Kidney DiseaseProteinuria

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

NCT07232537

Chronic Kidney DiseaseType 2 Diabetes Mellitus

RECRUITINGPhase 1/2

A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD)

NCT06721143

Chronic Kidney Disease Stage 3

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

NCT06278207

Chronic Kidney DiseaseType 2 Diabetes Mellitus

View all related studies

Contacts

Zulfitri 'Azuan bin Mat Daud, Dietitian Lecturer [Dr]

CONTACT

+60-397692431 zulfitri@upm.edu.my

Leong Sim Kian, Dietitian

CONTACT

Sponsors

Lead Sponsor

Universiti Putra Malaysia

Collaborators

International Society of Nephrology

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 4, 2025Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions